Loading…
Loading…

| NBIXNBIXNeurocrine Biosciences, Inc. | Neurocrine Biosciences, Inc. | $142.70 | $14.5B |
| AXSMAXSMAxsome Therapeutics, Inc. | Axsome Therapeutics, Inc. | $145.04 | $7.6B |
| XENEXENEXenon Pharmaceuticals Inc. | Xenon Pharmaceuticals Inc. | $35.34 | $3.4B |
| ACADACADAcadia Pharmaceuticals Inc. | Acadia Pharmaceuticals Inc. | $19.73 | $3.4B |
| DNLIDNLIDenali Therapeutics Inc. | Denali Therapeutics Inc. | $18.41 | $2.9B |
| SUPNSUPNSupernus Pharmaceuticals, Inc. | Supernus Pharmaceuticals, Inc. | $40.70 | $2.4B |
| RAPPRAPPRapport Therapeutics, Inc. Common Stock | Rapport Therapeutics, Inc. Common Stock | $25.93 | $1.2B |
| AVXLAVXLAnavex Life Sciences Corp. | Anavex Life Sciences Corp. | $1.33 | $123.3M |
| NMRANMRANeumora Therapeutics, Inc. Common Stock | Neumora Therapeutics, Inc. Common Stock | $0.38 | $71.3M |
| ADXNADXNAddex Therapeutics Ltd | Addex Therapeutics Ltd | $2.97 | $3.7M |